Astellas Pharma US, Inc.

Registered Principal Details

Business Or Interest:
Pharmaceuticals

Lobbying Interests:
Implementation of oral chemo parity legislation among stakeholders. Medicaid reform. ACA implementation in Wisconsin. Pharmaceutical innovation in Wisconsin.

CEO Name:
Yoshihiko Hatanaka

Contact
ML
Magdalena Lagowski
1 Astellas Way
Northbrook, IL 60062
(518) 885-8415
ccastro@multistate.com
http://www.us.astellas.com/

Authorized Lobbyists

Lobbyist Name Exclusive Duties Authorized On Withdrawn On

Lobbying Interests

Legislative Bills/Resolutions

Assembly Bill 752
Assembly Bill 752
Relating to: leave from employment for the purpose of serving as a bone marrow or organ donor and providing a penalty. (FE)

Bill Text and History

None
Notification Date
2/11/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 84
Senate Bill 84
Relating to: creating a Corrections System Formulary Board in the Department of Corrections, therapeutic alternate drug selections in the state correctional system, and granting rule-making authority. (FE)

Bill Text and History

2015 Wisconsin Act 40

None
Notification Date
4/13/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 138
Senate Bill 138
Relating to: information to be provided by insurers about health care plans offered on the American health benefit exchange.

Bill Text and History

None
Notification Date
5/20/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 517
Senate Bill 517
Relating to: leave from employment for the purpose of serving as a bone marrow or organ donor and providing a penalty. (FE)

Bill Text and History

2015 Wisconsin Act 345

None
Notification Date
2/11/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Topics Not Yet Assigned A Bill Or Rule Number

LRB 1843/1 and LRB 2078/1, relating to: information to be provided by insurers about health care plans offered on the American health benefit exchange
Development, drafting or introduction of a proposal relating to
LRB 1843/1 and LRB 2078/1, relating to: information to be provided by insurers about health care plans offered on the American health benefit exchange

Action Intended To Affect
Legislative matter

Notification Date
4/10/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Right to Treat
Development, drafting or introduction of a proposal relating to
Right to Treat

Action Intended To Affect
Legislative matter

Notification Date
1/28/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Total Lobbying Effort

  2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
Total Lobbying Expenditures 2015
January - June
$18,473.20
2015
July - December
$18,000.00
2016
January - June
$18,000.00
2016
July - December
$18,000.00
Total $72,473.20
Total Hours Communicating 2015
January - June
7.75
2015
July - December
2.00
2016
January - June
0.75
2016
July - December
0.50
Total 11.00
Total Hours Other 2015
January - June
5.50
2015
July - December
18.75
2016
January - June
6.75
2016
July - December
28.50
Total 59.50

Percent Allocation of Lobbying Effort

Legislative Bills/Resolutions

Relating to: creating a Corrections System Formulary Board in the Department of Corrections, therapeutic alternate drug selections in the state correctional system, and granting rule-making authority. (FE)
2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
2015
January - June
11%
2015
July - December
2016
January - June
2016
July - December
Total 1%
Relating to: information to be provided by insurers about health care plans offered on the American health benefit exchange.
2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
2015
January - June
14%
2015
July - December
2016
January - June
2016
July - December
Total 3%
Relating to: leave from employment for the purpose of serving as a bone marrow or organ donor and providing a penalty. (FE)
2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
2015
January - June
2015
July - December
2016
January - June
40%
2016
July - December
Total 4%

Budget Bill Subjects

No budget bill subjects found.

Administrative Rulemaking Proceedings

No administrative rulemaking proceedings found.

Topics Not Yet Assigned A Bill Or Rule Number

2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
2015
January - June
68%
2015
July - December
90%
2016
January - June
60%
2016
July - December
90%
Total 83%

Minor Efforts

(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)

Minor Efforts
2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
2015
January - June
7%
2015
July - December
10%
2016
January - June
2016
July - December
Total 4%

Other Matters

Includes time spent on:

  • Gubernatorial nominations
  • Matters on which the organization made no lobbying communication

Other Matters
2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
2015
January - June
2015
July - December
2016
January - June
2016
July - December
10%
Total 4%

Filed Statements of Lobbying Activity and Expenditures